Page last updated: 2024-11-05

tranexamic acid and Insulin Resistance

tranexamic acid has been researched along with Insulin Resistance in 1 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Insulin Resistance: Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.

Research Excerpts

ExcerptRelevanceReference
"These results suggest that in hemorrhagic shock elevated microvascular extracellular digestive enzyme activity causes insulin receptor dysfunction, hyperglycemia, and reduced ability to regulate blood glucose values."1.40Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock. ( DeLano, FA; Schmid-Schönbein, GW, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
DeLano, FA1
Schmid-Schönbein, GW1

Other Studies

1 other study available for tranexamic acid and Insulin Resistance

ArticleYear
Pancreatic digestive enzyme blockade in the small intestine prevents insulin resistance in hemorrhagic shock.
    Shock (Augusta, Ga.), 2014, Volume: 41, Issue:1

    Topics: Animals; Blood Glucose; Glucose Tolerance Test; Insulin Resistance; Intestine, Small; Male; Pancreas

2014